Commonwealth Equity Services
MTNB icon

Commonwealth Equity Services’s Matinas BioPharma MTNB Stock Holding History

Commonwealth Equity Services’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-64
Closed -$8K – 4151
2024
Q2 		$8K Sell
64
-2
-3% -$272 ﹤0.01% 4008
2024
Q1 		$13K Sell
66
-1
-1% -$178 ﹤0.01% 3979
2023
Q4 		$11K Buy
67
+1
+2% +$169 ﹤0.01% 3855
2023
Q3 		$6K Hold
66
– – ﹤0.01% 3798
2023
Q2 		$18K Buy
66
+27
+69% +$9.44K ﹤0.01% 3756
2023
Q1 		$13K Hold
39
– – ﹤0.01% 3703
2022
Q4 		$14K Hold
39
– – ﹤0.01% 3623
2022
Q3 		$18K Hold
39
– – ﹤0.01% 3589
2022
Q2 		$23K Hold
39
– – ﹤0.01% 3561
2022
Q1 		$23K Hold
39
– – ﹤0.01% 3648
2021
Q4 		$29K Sell
39
-31
-44% -$24.9K ﹤0.01% 3576
2021
Q3 		$68K Buy
70
+21
+43% +$13.6K ﹤0.01% 3470
2021
Q2 		$28K Hold
49
– – ﹤0.01% 3490
2021
Q1 		$38K Buy
49
+10
+26% +$10.1K ﹤0.01% 3351
2020
Q4 		$39K Buy
39
+3
+8% +$2.08K ﹤0.01% 3146
2020
Q3 		$20K Hold
36
– – ﹤0.01% 3013
2020
Q2 		$20K Hold
36
– – ﹤0.01% 2911
2020
Q1 		$16K Buy
36
+12
+50% +$10.9K ﹤0.01% 2771
2019
Q4 		$40K Buy
24
+1
+4% +$869 ﹤0.01% 2817
2019
Q3 		$10K Hold
23
– – ﹤0.01% 2817
2019
Q2 		$14K Buy
23
+1
+5% +$721 ﹤0.01% 2753
2019
Q1 		$17K Buy
22
+8
+57% +$6.46K ﹤0.01% 2711
2018
Q4 		$6K Hold
14
– – ﹤0.01% 2664
2018
Q3 		$9K Hold
14
– – ﹤0.01% 2777
2018
Q2 		$4K Hold
14
– – ﹤0.01% 2762
2018
Q1 		$7K Hold
14
– – ﹤0.01% 2704
2017
Q4 		$12K Hold
14
– – ﹤0.01% 2661
2017
Q3 		$13K Hold
14
– – ﹤0.01% 2543
2017
Q2 		$17K Buy
+14
New +$28.2K ﹤0.01% 2490

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Sanctuary Advisors
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Commonwealth Equity Services's MTNB Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 64 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in MTNB in Q2 2017 and held it in 29 quarters. The position peaked at $68K in Q3 2021. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • Commonwealth Equity Services reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 64 Matinas BioPharma shares in Q3 2024, an estimated $8K.
  • Commonwealth Equity Services first reported a position in Matinas BioPharma in Q2 2017 and held it in 29 quarters.
  • Commonwealth Equity Services's Matinas BioPharma position peaked at $68K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.